BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kutaiba N, Ardalan Z. Risk factors and screening intervals are crucial to evaluating the cost effectiveness of abbreviated MRI in HCC screening. J Hepatol 2021:S0168-8278(21)01892-4. [PMID: 34242701 DOI: 10.1016/j.jhep.2021.06.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gupta P, Sharma V, Kalra N. Reply to: "Risk factors and screening intervals are crucial for evaluating the cost effectiveness of abbreviated MRI in HCC screening". J Hepatol 2021;75:1259-60. [PMID: 34437909 DOI: 10.1016/j.jhep.2021.08.002] [Reference Citation Analysis]
2 Pavlides M, Francis S, Barnes E. Abbreviated MRI to screen for HCC in patients with cirrhosis. A step forward but a long road ahead. J Hepatol 2021:S0168-8278(21)02169-3. [PMID: 34762998 DOI: 10.1016/j.jhep.2021.10.027] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]